FDA Inspection 1049694 — SpecGx LLC

SpecGx LLC — FEI 1317295

The FDA completed an inspection of SpecGx LLC on Apr 6, 2018 in Hobart, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 6, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hobart, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.